SEP 02, 2019 3:56 PM PDT

Treating glioblastomas through the bloodstream

New research published in Nature Communications details a novel immunotherapy that is capable of treating brain cancer via the bloodstream. Although only proven thus far in mice, the nano-immunotherapy has the potential to change the way we treat glioblastoma, the most common and aggressive form of brain cancer, forever.

New research uses nano-immunotherapy to target brain tumors via the bloodstream. Photo: Pixabay

The technology uses checkpoint inhibitor drugs in order to disarm brain tumors that fight against the immune system. But the key in this therapy is its ability to cross the blood-brain barrier – at least in mice.

"Although our findings were not made in humans," says senior study author Julia Y. Ljubimova, a professor of neurosurgery and biomedical sciences at Cedars-Sinai Medical Center in Los Angeles, CA, "they bring us closer to developing a treatment that might effectively attack brain tumors with [systemic] drug administration."

How did they do this? Well, because brain tumors suppress attack from anticancer cells using macrophages and T regulatory cells, the researchers decided to try to block them using checkpoint inhibitor drugs so that the immune system can properly activate cancer-killing cells. Using a small transporter protein to carry an inhibitor drug across the blood-brain barrier, the researchers were able to target the macrophages and T regulatory cells systemically, i.e. through the bloodstream.

Although brain cancer is not particularly common, it does account for more than its fair share of cancer deaths. According to the National Cancer Institute, 23,820 people in the United States will find out that they have brain cancer in 2019, and 17,760 will die of the disease in this same year.

While the new immunotherapy has a ways to go before it will be ready for human trials, Professor Ljubimova says, "We hope that by delivering multifunctional new-generation drugs through the blood-brain barrier, we can explore new therapies for many neurological conditions."

Sources: Medical News Today, Nature Communications

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
SEP 11, 2020
Cancer
Taking cancer treatment from a whole new angle
SEP 11, 2020
Taking cancer treatment from a whole new angle
New cancer research is looking at treatment for the disease from an entirely new angle: structurally. While chemotherapy ...
SEP 28, 2020
Cancer
A New Transcriptomics Program in the Works Glioma Diagnosis
SEP 28, 2020
A New Transcriptomics Program in the Works Glioma Diagnosis
The future of medicine is “personalized healthcare.” However, testing remains a critical hurdle researcher&r ...
OCT 14, 2020
Cancer
Research suggests statins could reduce the risk of cancer
OCT 14, 2020
Research suggests statins could reduce the risk of cancer
New research published in the journal eLife provides evidence that statins, the common cholesterol-lowering drugs, could ...
NOV 23, 2020
Cancer
Platelets May Protect Cancer Against PD-1 Therapies
NOV 23, 2020
Platelets May Protect Cancer Against PD-1 Therapies
One of cancer’s greatest tools is its ability to manipulate the immune system. Many cancer therapies have arisen t ...
NOV 13, 2020
Cancer
Predictive model assesses risk of adverse side effects for chemotherapy patients
NOV 13, 2020
Predictive model assesses risk of adverse side effects for chemotherapy patients
New research published in npj Systems Biology and Applications showcases a model capable of predicting which patien ...
NOV 20, 2020
Cancer
How does tissue geometry influence cancer cellular migration?
NOV 20, 2020
How does tissue geometry influence cancer cellular migration?
A team of researchers led by UC Santa Barbara's Distinguished Professor Denise Montell has recently published new fi ...
Loading Comments...